Cargando…

PD-L1 Biomolecules Associated with Clinical Features in Non-Melanoma Skin Cancer [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128146/ https://www.ncbi.nlm.nih.gov/pubmed/37114035 http://dx.doi.org/10.2147/CCID.S417684

Ejemplares similares

PD-L1 Biomolecules Associated with Clinical Features in Non-Melanoma Skin Cancer
por: Li, Dan, et al.
Publicado: (2023)

Corrigendum to “Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer”
por: Bari, Shahla, et al.
Publicado: (2019)

Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum]
Publicado: (2021)

miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 [Corrigendum]
Publicado: (2020)

Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
Publicado: (2022)

Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021)

Corrigendum to “The Role of Antioxidants in Skin Cancer Prevention and Treatment”
por: Godić, Aleksandar, et al.
Publicado: (2020)

Correction of acknowledgments: PD-L1 testing in non-small cell lung cancer: past, present, and future
por: Kim, Hyojin, et al.
Publicado: (2020)

PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma
por: Sharma, Gaurav, et al.
Publicado: (2022)

Corrigendum to “Radiological Features of Gastrointestinal Lymphoma”
por: Lo Re, Giuseppe, et al.
Publicado: (2016)

Corrigendum to “Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo”
por: Ho, Mao-Lin, et al.
Publicado: (2015)

Corrigendum to “Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma”
por: Macià, A., et al.
Publicado: (2016)

Ex vivo distribution of gold nanoparticles in choroidal melanoma [Corrigendum]
Publicado: (2018)

[Corrigendum] Melanogenesis in uveal melanoma cells: Effect of argan oil
por: Caporarello, Nunzia, et al.
Publicado: (2023)

Corrigendum to “Gender and Ethnicity Based Differences in Clinical and Laboratory Features of Myasthenia Gravis”
por: Abukhalil, Fawzi, et al.
Publicado: (2021)

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
por: Babiker, HM, et al.
Publicado: (2019)

CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
Publicado: (2019)

A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive Skin [Corrigendum]
Publicado: (2023)

A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers [Corrigendum]
Publicado: (2022)

Corrigendum to “Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction”
por: Ahmad, Ijaz, et al.
Publicado: (2017)

Corrigendum to: Calcium Signaling in the Photodamaged Skin: In Vivo Experiments and Mathematical Modeling
Publicado: (2022)

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
por: Li, Zhilin, et al.
Publicado: (2022)

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum]
Publicado: (2019)

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
por: Karivedu, Vidhya, et al.
Publicado: (2019)

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078]
por: Banna, G.L., et al.
Publicado: (2021)

Corrigendum to “Recurrent Syncope Associated with Lung Cancer”
por: Zhang, Dingguo, et al.
Publicado: (2016)

Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Publicado: (2021)

Painful tumors of the skin: “CALM HOG FLED PEN AND GETS BACK” [Corrigendum]
Publicado: (2019)

Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A [Corrigendum]
Publicado: (2019)

Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma [Corrigendum]
Publicado: (2017)

Corrigendum: Increased Melanoma-Associated Antigen C2 Expression Affords Resistance to Apoptotic Deathin Suspension-Cultured Tumor Cells
por: Park, Doyeon, et al.
Publicado: (2022)

Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus [Corrigendum]
Publicado: (2018)

Corrigendum to “GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma”
por: Piñón-Zárate, Gabriela, et al.
Publicado: (2015)

Corrigendum to “Chromosome 3p Inverted Duplication with Terminal Deletion: Second Postnatal Case Report with Additional Clinical Features”
por: Riley, Jacquelyn D., et al.
Publicado: (2019)

Corrigendum to “Clinical Features of Brain Metastases in Small Cell Lung Cancer: an Implication for Hippocampal Sparing Whole Brain Radiation Therapy”. [Transl. Oncol. 10(1) 2017:54-58]
por: Guo, Wen-Long, et al.
Publicado: (2017)

Corrigendum: Optical coherence tomography features in a case of Type I sialidosis
Publicado: (2020)

Corrigendum to “SDF2L1 Inhibits Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma”
por: Zhang, Liqian, et al.
Publicado: (2022)

Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma [Corrigendum]
Publicado: (2022)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
por: Redman, Jason M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t112e79v0ob9gprm5n5opsa8bc